Scanmed S.A.

Clinical research at this site focuses on cardiovascular diseases, with studies centered on major heart and blood vessel conditions such as acute coronary syndrome, myocardial infarction, and heart failure. The trials are designed to assess whether new approaches can better protect patients from serious cardiac complications and improve outcomes after urgent cardiovascular events.

• Testing a new treatment approach to lower the risk of major adverse cardiovascular events after acute myocardial infarction
• Evaluating whether metformin can reduce the need for unplanned coronary revascularization in patients treated for acute coronary syndrome
• Studying whether finerenone can help reduce heart failure events and cardiovascular death in hospitalized patients with heart failure

The research portfolio at Scanmed S.A. reflects a strong interest in improving treatment effectiveness, reducing inflammation-related cardiovascular risk, and finding better ways to support patients during and after serious cardiac events.